Simona Zanzola

USPTO Granted Patents = 9 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 24(Granted Patents)

Company Filing History:

Rotta Research Laboratorium

patents

1 out of 1

Rotta Research Laboraturium S.p.a.

patent

Years Active: 2006-2014

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8633208 - 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands (2014-01-21),

2. 8193353 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2012-06-05),

3. 7994181 - 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents (2011-08-09),

4. 7968558 - Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents (2011-06-28),

5. 7906501 - Pyrrole derivatives with angiotensin II antagonist activity (2011-03-15),

6. 7674809 - Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production (2010-03-09),

7. 7560591 - Benzamidine derivatives having anti-inflammatory and immunosuppressive activity (2009-07-14),

8. 7202277 - Benzamidine derivatives having anti-inflammatory and immunosuppressive activity (2007-04-10),

9. 7145037 - Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them (2006-12-05),

Title: Simona Zanzola: Innovator in Pharmaceutical Chemistry

Introduction

Simona Zanzola is a prominent inventor based in Milan, Italy, known for her significant contributions to pharmaceutical chemistry. With a total of nine patents to her name, she has made remarkable advancements in the development of new therapeutic agents.

Latest Patents

Zanzola's latest patents include innovative compounds such as 6-1H-imidazo-quinazoline and quinolines derivatives, which serve as new Monoamine Oxidase (MAO) inhibitors and Imidazoline Receptor ligands. These compounds are designed to treat various conditions, including depression, Parkinson's disease, and drug dependence. Additionally, she has developed potent analgesics and anti-inflammatory agents that target pain and inflammatory disorders. These compounds have shown effectiveness in managing both inflammatory and neuropathic pain, as well as potential applications in cancer treatment.

Career Highlights

Throughout her career, Zanzola has worked with notable companies such as Rottapharm Spa and Rotta Research Laboratorium S.p.a. Her work has been instrumental in advancing the field of pharmacology, particularly in the development of new medications that address complex health issues.

Collaborations

Zanzola has collaborated with esteemed colleagues, including Francesco Makovec and Lucio C Rovati, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Simona Zanzola's contributions to pharmaceutical chemistry highlight her as a leading inventor in the development of innovative therapeutic agents. Her work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.